Novel Pulmonary Hypertension Drug From Bayer Shows Modest Promise In Phase 3 Trials 1

A new drug appears to have promising– but not game-changing– effects in people with two forms of pulmonary hypertension. Riociguat, a soluble guanylate cyclase stimulator under development by Bayer, is thought to have vasodilating, antiproliferative and antifibrotic effects.

Results of two phase 3 placebo-controlled trials were published today in the New England Journal of Medicine. CHEST-1 studied the clinical impact of riociguat in 262 patients with chronic thromboembolic pulmonary hypertension; PATENT-1 studied the the drug in 443 patients with pulmonary arterial hypertension.

Click here to read the full story on Forbes, including a comment from pulmonary hypertension expert John Ryan.

 

Ball-and-stick model of the riociguat molecule...

 

Advertisements

One comment

  1. Pingback: Celebs Take Aim at Anthony Weiner on Twitter | HotCelebritiesMagazine.com – Hot Hollywood Celebrity Gossip

What do you think?

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s